Suspends Use Of Actos Over Cancer Risk!

Actos

While it remains FDA diabetes drug that map Takeda Pharmaceuticals for risks of bladder cancer, suspend your use of the French regulatory authority on the pill, as well as the Takeda Competact, after examining the data on pharmacovigilance and the results of a new study found an increased risk. Actos, Medications are currently taken by about 230,000 people in France.
Actos


Suspends Use Of Actos Over Cancer Risk!